The company has received Abbreviated New Drug Application (ANDA) final approval from the US Food and Drug Administration (US FDA) for Memantine Hydrochloride Tablets USP, 5 mg and 10 mg, the generic version of Namenda Tablets, 5 mg and 10 mg® (of Forest Laboratories), which is used for treatment of moderate to severe dementia in patients with Alzheimer’s disease.
| Subscribe To Our Free Newsletter |
